Gerd Sutter

LMU Klinikum — Germany

Immunology and Microbiology · Life Sciences

62h-index13.3kcitations277works5.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Poxvirus research and outbreaks(83), Virus-based gene therapy research(80), Herpesvirus Infections and Treatments(61), Immunotherapy and Immune Responses(58), SARS-CoV-2 and COVID-19 Research(43)

Publications276 total

Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19
Vaccines·2024· 5 citedOpen Access
The Safety, Immunogenicity, and Optimal Dosing of an MVA-Based Vaccine Against MERS Coronavirus in Healthy Adults: A Phase 1b, Randomised, Placebo-Controlled, Double-Blind Clinical Trial
SSRN Electronic Journal·2024· 4 citedOpen Access
MVA-ST Vaccination in an Aged-Hamster Model for COVID-19 Overcomes Age-Related Immune Dysfunction and Robustly Activates T Cells and Antibodies
Preprints.org·2023· 1 citedOpen Access
2343. SARS-CoV-2 Spike Conformation Essentially Influences Vaccine Immunogenicity – Results from Two Clinical Phase I Trials of the Vector Vaccine Candidates MVA-SARS-2-S and MVA-SARS-2-ST
Open Forum Infectious Diseases·2023Open Access
Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy Adults
Investigative Radiology·2023· 21 citedOpen Access
The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice
Frontiers in Cellular and Infection Microbiology·2023· 6 citedOpen Access
Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice
Frontiers in Immunology·2023· 12 citedOpen Access
Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice
Pathogens·2023· 7 citedOpen Access
Immunisierung mit MVA-Vektorimpfstoffen schützt K18-hACE2 Mäuse vor SARS- CoV-2 vermittelten, pathologischen Veränderungen im ZNS
Tierärztliche Praxis Ausgabe K Kleintiere / Heimtiere·2023
Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice
Viruses·2023· 8 citedOpen Access
MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination
Emerging infectious diseases·2023· 2 citedOpen Access
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
Frontiers in Immunology·2023· 9 citedOpen Access
Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease
Cancer Gene Therapy·2023· 25 citedOpen Access
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice
Vaccines·2023· 5 citedOpen Access
Der Huchen stirbt aus – was tun? Gefährdungsfaktoren und notwendige Maßnahmen in Bayern und Österreich
Zenodo (CERN European Organization for Nuclear Research)·2023· 4 citedOpen Access
Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251
Nature Communications·2023· 2 citedOpen Access
Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome–Coronavirus Spike Protein
The Journal of Infectious Diseases·2023· 13 citedOpen Access
Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity
Journal of Clinical Investigation·2022· 32 citedOpen Access
Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance
JHEP Reports·2022· 8 citedOpen Access
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
Nature Communications·2022· 20 citedOpen Access
← Previouspage 2 of 14Next →

Frequent Co-authors

Ingo Drexler(12), Asisa Volz(10), Volker Erfle(10), Caroline Staib(8), Robert Fux(7), Bernard Moss(5), Albert D. M. E. Osterhaus(5), Reinhold Förster(4), Bart L. Haagmans(4), Stephan Becker(4), Joost H. C. M. Kreijtz(4), Guus F. Rimmelzwaan(4), Holger Ludwig(3), David C. Montefiori(3), Yasemin Suezer(3), Nisreen M.A. Okba(3), Ulrich Kalinke(3), Chenxi Wang(3), David B. Allison(3), David I. Watkins(3)